US Patent 9988397 ERK inhibitors
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+578 characters)
Article
Patent abstract
The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are ERK2 inhibitors. The invention also provides a method of inhibiting ERK2 in a patient in need of such treatment comprising administering to said patient an effective amount of at least one compound of Formula (I). The invention also provides a method for treating cancer in a patient in need of such treatment, said method comprising administering to said patient an effective amount of at least one compound of Formula (I).
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
David L. Sloman0
David Witter0
Jianmin Fu0
Joseph Kozlowski0
Phieng Siliphaivanh0
Umar Faruk Mansoor0
Wei Liu0
Xianhai Huang0
Yimin Qian0
Zhilong Wan0
Ziping Liu0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09988397 ERK inhibitors US Patent 9988397 ERK inhibitors
Infobox
Patent Number
099883970
Patent Number
99883970
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
099883970
Date of Patent
June 5, 2018
0Patent Application Number
155317710
Date Filed
December 10, 2015
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09988397 ERK inhibitors
Infobox
Is a
Patent jurisdiction
Patent number
09988397
Date of patent
June 5, 2018
Patent application number
15531771
Date Filed
December 10, 2015
Patent primary examiner
Find more entities like US Patent 9988397 ERK inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
